Methadone enhances the effectiveness of 5-aminolevulinic acid-based photodynamic therapy for squamous cell carcinoma and glioblastoma in vitro
Methadone enhances the effectiveness of 5-aminolevulinic acid-based photodynamic therapy for squamous cell carcinoma and glioblastoma in vitro
复制标题
美沙酮增强基于 5-氨基乙酰丙酸的光动力疗法对鳞状细胞癌和胶质母细胞瘤的体外疗效
DOI:
10.1002/jbio.201800468
复制
发表时间:
2019
影响因子:
2.8
通讯作者:
Sroka Ronald
中科院分区:
文献类型:
--
作者:
Shi Lei;Buchner Alex;er;Pohla Heike;Pongratz Thomas;Ruehm Adrian;Zimmermann Wolfgang;Gederaas Odrun A;Zhang Linglin;Wang Xiuli;Stepp Herbert;Sroka Ronald
Although having shown promising clinical outcomes, the effectiveness of 5‐aminolevulinic acid‐based photodynamic therapy (ALA‐PDT) for squamous cell carcinoma (SCC) and glioblastoma remains to be improved. The analgesic drug methadone is able to sensitize various tumors to chemotherapy. In this in vitro study, the influence of methadone to the effectiveness of ALA‐PDT for SCC (FADU) and glioblastoma (A172) was investigated on the protoporphyrin IX (PpIX) fluorescence, survival rates, apoptosis, and cell cycle phase, each with or without the presence of methadone. The production of PpIX was increased by methadone in FADU cells while it was decreased in A172 cells. The survival rates of both cell lines treated by ALA‐PDT were significantly reduced by the combination with methadone (P< .05). Methadone also significantly increased the percentage of apoptotic cells and improved the effect of ALA‐PDT on the cell cycle phase arrest in the G0/G1 phase (P< .05). This study demonstrates the potential of methadone to influence the cytotoxic effect of ALA‐PDT for both SCC and glioblastoma cell lines.